Pharmaceutical Research

, Volume 27, Issue 8, pp 1746–1749

Application of Nanotechnology in Cosmetics

Commentary

REFERENCES

  1. 1.
    The US National Nanotechnology Initiative (NNI). http://www.nano.gov/html/about/home_about.html.
  2. 2.
    Buzea C, Pacheco Blandino II, Robbie K. Nanomaterials and nanoparticles: Sources and toxicity. Biointerphases. 2007;2(4):MR17–172.CrossRefPubMedGoogle Scholar
  3. 3.
    Oberdörster G, Oberdörster E, Oberdörster J. Nanotoxicology: an emerging discipline from studies of ultrafine particles. Environ Health Perspect. 2005;113(7):823–39.CrossRefPubMedGoogle Scholar
  4. 4.
    Ryman-Rasmussen JP, Cesta MF, Brody AR, Shipley-Phillips JK, Everitt JI, Tewksbury EW et al. Inhaled carbon nanotubes reach the subpleural tissue in mice. Nat Nano. 2009;4:747–51.CrossRefGoogle Scholar
  5. 5.
    U.S. Food and Drug Administration, Nanotechnology Task Force Report. July 2007. http://www/fda.gov/nanotechnology/taskforce/report2007.html.
  6. 6.
    Padamwar MN, Pokharkar VB. Development of vitamin loaded liposomal formulations using factorial design approach: drug deposition and stability. Int J Pharm. 2006;320:37–44.CrossRefPubMedGoogle Scholar
  7. 7.
    Touitou E, Junginger HE, Weiner ND, Nagai T, Mezei M. Liposomes as carriers for topical and transdermal delivery. J Pharm Sci. 1994;83(9):1189–203.CrossRefPubMedGoogle Scholar
  8. 8.
    Lens M. Use of fullerenes in cosmetics. Recent Patents on Biotechnology. 2009;3:118–23.CrossRefPubMedGoogle Scholar
  9. 9.
    Petersen R. Nanocrystals for use in topical cosmetic formulations and method of production thereof. Abbott GmbH & Co. US Patent 60/866233 (2008).Google Scholar
  10. 10.
    L’Oréal. Use of hyperbranched polymers and dendrimers comprising a particular group as film-forming agent, film-forming compositions comprising same and use particularly in cosmetics and pharmaceutics. US Patent 6432423, (2002).Google Scholar
  11. 11.
    Pardeike J, Hommoss A, Müller RH. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm. 2009;366:170–84.CrossRefPubMedGoogle Scholar
  12. 12.
    Schäfer-Korting M, Mehnert W, Korting HC. Lipid nanoparticles for improved topical application of drugs for skin diseases. Adv Drug Deliv Rev. 2007;59:427–43.CrossRefPubMedGoogle Scholar
  13. 13.
    Villalobos-Hernàndez JR, Müller-Goymann CC. Sun protection enhancement of titanium dioxide crystals by the use of carnauba wax nanoparticles: The synergistic interaction between organic and inorganic sunscreens at nanoscale. Int J Pharm. 2006;322:161–70.CrossRefPubMedGoogle Scholar
  14. 14.
    Friends of the Earth. http://www.foe.org. Nanomaterials, sunscreens and cosmetics: Small Ingredients, Big Risks, (2006).
  15. 15.
    Mavon A, Miquel C, Lejeune O, Payre B, Moretto P. In vitro percutaneous absorption and in vivo stratum corneum distribution of an organic and a mineral sunscreen. Skin Pharmacol Physiol. 2007;20:10–20.CrossRefPubMedGoogle Scholar
  16. 16.
    Jowsey IR, Basketter DA, Westmoreland C, Kimber IA. A future approach to measuring relative skin sensitising potential: a proposal. J Appl Toxicol. 2006;26(4):341–50.CrossRefPubMedGoogle Scholar

Copyright information

© US Government 2010

Authors and Affiliations

  1. 1.Division of Toxicology, Office of Applied Research and Safety Assessment, Center for Food Safety and Applied NutritionUS Food and Drug AdministrationLaurelUSA

Personalised recommendations